This review might fall into said category but hopefully with more care and fewer typos.  The book Yesteryear is gripping and ...

Jacinta Allan’s resignation brings new Victorian Premier Ben Carroll to the podium to campaign in advance of November state ...

Geneva Convention requires signatories to press for an investigation, but Dutch reports of Australian actions went "missing".

General advice warning: This material is for information purposes only and should not be construed as an offer or solicitation or recommendation to buy or sell any financial products. Any advice ...

MOU falls apart over Straits of Hormuz and Lebanon, as Iran strikes across the Gulf and petitions UN Security Council.

I (Growthgauge here) have been following the turnaround of Kip McGrath Education Centres for a couple of years now, and you can find my earlier articles here. Below, I’ve sketched out the turnaround ...

Now, as bad as it seems, the above result was expected, and the market was well informed about it prior to these results, so I don’t think these numbers drove the share price decline from around $6 ...

This morning, Energy One (ASX: EOL) released its results for H1 FY 2026, reporting revenue growth of 21% to $34.8 million, and net profit after tax growth of 61% to $4m. Over 90% of the revenue is ...

The corkwood tree, and other native plants in the Duboisia genus, were being used in indigenous Australian medicine since at least the first written records from when the English arrived in 1770. But ...

This morning, radiology software provider Pro Medicus (ASX: PME) reported its results for H1 FY 2026. Revenue was $124.8 million, up 28.4%, while underlying profit after tax (excluding fair value ...

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

This morning, radiology software company Pro Medicus (ASX: PME) reported its results for the first half of 2024, and in response, the share price has fallen around 11% from $108 to $95.70 at the time ...